Tel: +7 727 258 28 21
Email: eurobak@eurobak.kz

Takeda

  • Segment:
  • Chief:Sabira Salykhova, Director of Takeda Kazakhstan

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.

Arrange a meeting with us



    * Required fields



    By clicking the "Submit" button, you agree to the processing of personal data, as described in the EUROBAK Privacy Policy


    This will close in 0 seconds

    SEND US AN E-MAIL


      * Required fields

      By clicking the "Submit" button, you agree to the processing of personal data, as described in the EUROBAK Privacy Policy

      This will close in 0 seconds


      This will close in 0 seconds